Olav Hellebø
CEO
ReNeuron
Biography
Olav Hellebø joined ReNeroun group in the UK as CEO in 2014. Previously he was CEO of the oncology biotech Clavis Pharma in Oslo, Norway. He joined Clavis from UCB where he was Senior Vice President and built the global organization responsible for the successful registration and launch of the anti-TNF Cimzia®.
From 2003 to 2004 Mr Hellebø was COO of Novartis UK and prior to that held a series of senior roles spanning a decade at Schering Plough, including US marketing director for Claritin, Managing Director for the UK subsidiary and Vice President and head of the Biotech and Oncology Business Unit in the USA.
Mr. Hellebo graduated Summa Cum Laude in international business studies from Hofstra University, New York and earned an MBA from IESE, Barcelona.